The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure
✍ Scribed by Danielle P. Cavalcanti; Stênio P. Fragoso; Samuel Goldenberg; Wanderley de Souza; Maria Cristina M. Motta
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 929 KB
- Volume
- 94
- Category
- Article
- ISSN
- 1432-1955
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Low concentrations of novobiocin are toxic to permeable yeast cells, but do not inhibit type II topoisomerase activity. Furthermore, the enzyme does not bind specifically to novobiocin-Sepharose. These observations are in agreement with genetical analyses. Mutations at a single locus that confer nov
A fluorescence image cytometry technique was developed to measure the effects of topotecan, a topoisomerase I inhibitor, on the nuclear expression of topoisomerase IIa in a series of patients with refractory or relapsed acute myeloid leukemia (AML). W e used a commercially available affinitypuritied
## Abstract Acetylation of histones leads to conformational changes of DNA. We have previously shown that the histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induced cell cycle arrest, differentiation, and apoptosis. In addition to their antitumor effects as single age